These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders. Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436 [TBL] [Abstract][Full Text] [Related]
9. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease. Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687 [TBL] [Abstract][Full Text] [Related]
10. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests. Chang CC; Liu JS; Chang YY; Chang WN; Chen SS; Lee CH Eur J Neurol; 2008 Jan; 15(1):61-5. PubMed ID: 18042240 [TBL] [Abstract][Full Text] [Related]
11. Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease. Ham JH; Cha J; Lee JJ; Baek GM; Sunwoo MK; Hong JY; Shin NY; Sohn YH; Lee JM; Lee PH Neuroimage; 2015 Oct; 119():296-304. PubMed ID: 26143204 [TBL] [Abstract][Full Text] [Related]
12. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination. Wakamori T; Agari T; Yasuhara T; Kameda M; Kondo A; Shinko A; Sasada S; Sasaki T; Furuta T; Date I Parkinsonism Relat Disord; 2014 Apr; 20(4):415-20. PubMed ID: 24467818 [TBL] [Abstract][Full Text] [Related]
13. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease. Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657 [TBL] [Abstract][Full Text] [Related]
15. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study. Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029 [TBL] [Abstract][Full Text] [Related]
16. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075 [TBL] [Abstract][Full Text] [Related]
17. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573 [TBL] [Abstract][Full Text] [Related]
18. Brain perfusion alterations in depressed patients with Parkinson's disease. Kim YD; Jeong HS; Song IU; Chung YA; Namgung E; Kim YD Ann Nucl Med; 2016 Dec; 30(10):731-737. PubMed ID: 27566684 [TBL] [Abstract][Full Text] [Related]
19. Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. Rodriguez G; Morbelli S; Brugnolo A; Calvini P; Girtler N; Piccardo A; Dougall NJ; Ebmeier KP; Baron JC; Nobili F Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1186-92. PubMed ID: 15931515 [TBL] [Abstract][Full Text] [Related]
20. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction. Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]